cbdMD Inc YCBD

Morningstar Rating
$0.41 −0.02 (5.01%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

YCBD is trading at a LOCK|hHDhkH premium.
Price
$0.43
Fair Value
LOCK|VP&HCjQ
Uncertainty
LOCK|R< L&t^#
1-Star Price
LOCK|MRK^P^Y
5-Star Price
LOCK|vMbX&g
Economic Moat
LOCK|vm
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.43
Day Range
$0.41–0.43
52-Week Range
$0.41–2.56
Bid/Ask
$0.42 / $0.43
Shares Outstanding
11.21M
Market Cap
$4.57M
Volume/Avg
127,815 / 436,481

Key Statistics

Price/Earnings (Normalized)
1.60
Price/Sales
0.20
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
42

Valuation

Metric
YCBD
Price/Earnings (Normalized)
1.60
Price/Book Value
0.58
Price/Sales
0.20
Price/Cash Flow
—
Price/Earnings
YCBD

Financial Strength

Metric
YCBD
Quick Ratio
1.26
Current Ratio
2.50
Interest Coverage
—
Quick Ratio
YCBD

Profitability

Metric
YCBD
Return on Assets (Normalized)
−21.86%
Return on Equity (Normalized)
−31.55%
Return on Invested Capital (Normalized)
−28.22%
Return on Assets
YCBD

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|>xq%kCRLOCK|mK?C!$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|H^Z@m!qLOCK|kdr&$46B
Haleon PLC ADR
HLN
LOCK|?@@$G?LOCK|@$r$39B
Zoetis Inc Class A
ZTS
LOCK|@k?#C%!LOCK|DFF$30B
Viatris Inc
VTRS
LOCK|$GqP^m!LOCK|$S$20B
Elanco Animal Health Inc
ELAN
LOCK|?sLOCK|YP$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|Y%$b#qLOCK|ZF$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|qPDJ^qJLOCK|>%$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|nTCfsWLOCK|&?!yh$2B
Perrigo Co PLC
PRGO
LOCK|SR?%&#PLOCK|pY>$2B

Sponsor Center